Sucampo Announces Resignation of CFO Jan Smilek
Sucampo Pharmaceuticals, an international biopharmaceutical company, has announced that Jan Smilek, chief financial officer (CFO) and vice president, finance, has resigned to pursue other opportunities. The company will initiate search for a new CFO.
Smilek joined Sucampo in February 2008 as vice president of finance and corporate controller. In August 2008, he was appointed acting CFO and in December 2009 he was appointed CFO. Prior to joining Sucampo, Smilek was the senior director of finance at Vanda Pharmaceuticals.